Pharmacists’ Role in Helping Patients Manage COPD | ASHP Midyear
Drug Topics
DECEMBER 12, 2024
Lourdes Cross, PharmD, BCACP, CDCES, discussed chronic obstructive pulmonary disease and how pharmacists are positioned to help patients exacerbations.
Thu.Dec 12, 2024
186 
CDC finds no evidence of bird flu virus in California toddler
STAT
DECEMBER 12, 2024
Testing of samples taken from a child in California thought to have contracted H5N1 bird flu after drinking raw milk turned up no evidence of influenza viruses, the Centers for Disease Control and Prevention said Thursday. A test run on a sample from the child — who went to a Marin County emergency department last week with a fever and vomiting — had been positive there for flu A.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
FDA Reports Serious Liver Injury in Patients Without Cirrhosis Using Obeticholic Acid to Treat PBC
Pharmacy Times
DECEMBER 12, 2024
This update follows May 2021 guidelines which recommended patients with primary biliary cholangitis (PBC) with advanced cirrhosis discontinue obeticholic acid.
STAT+: AI versus AI: The emerging arms race over health insurance denials
STAT
DECEMBER 12, 2024
Like many Americans, Holden Karau said she was fed up with health insurance. The software engineer’s disillusionment began in 2019, when her insurer, UnitedHealthcare, balked at covering physical therapy after she was hit by a car and could not walk. She said the hassles piled on stress, forced her to pay more out of pocket, and delayed access to care she needed to recover from multiple broken bones.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Nobel laureates ‘strongly urge’ Senate to oppose confirmation of RFK Jr
Pharmaceutical Technology
DECEMBER 12, 2024
In the letter, 77 Nobel Prize winners argue that appointing RFK as Secretary of HHS would put the US publics health in jeopardy.
Opinion: What I’ve learned — the hard way — about AI in bio
STAT
DECEMBER 12, 2024
As we approach the end of 2024, First Opinion is publishing a series of essays on the state of AI in medicine and biopharma. There’s more to life than protein folding.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Opinion: In a threat to patient trust, Texas hospitals must ask ‘Are you a U.S. citizen?’
STAT
DECEMBER 12, 2024
As a first-generation immigrant, much of my childhood was spent in a state of perpetual uncertainty. My family and I fixated on an ever-refreshing screen, patiently watching our status shift from “H-1B visa” to “green card” holder to “citizen” over 14 long years. Yet amid this endless cycle of anxiety, one place surprisingly gave me solace: the hospital.
Pharmacy-Driven Vaccine Clinic to Reduce Number of Children Missing School | ASHP Midyear
Drug Topics
DECEMBER 12, 2024
Researchers presented the community-wide benefits of a collaborative pharmacy-driven vaccine clinic in an urban setting.
STAT+: Arcellx won the battle of BCMA CAR-T therapies
STAT
DECEMBER 12, 2024
This story first appeared in Adam’s Biotech Scorecard, a subscriber-only newsletter. STAT+ subscribers can sign up here to get it delivered to their inbox. I just returned from San Diego and the annual meeting of the American Society of Hematology, where Arcellx won the battle of BCMA CAR-T therapies against Legend Biotech. Legend has downplayed the significance of the 12-17% rate of delayed neurotoxicity — Parkinsonian symptoms and cranial nerve palsies — report
Pharmacists Play Key Role in Educating Patients About RSV Vaccine | ASHP Midyear
Drug Topics
DECEMBER 12, 2024
A conversation with Chelsea Keedy, PharmD, BCACP, clinical assistant professor at the University of Georgia.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
When AI becomes a tool to fight insurance denials
STAT
DECEMBER 12, 2024
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Companies use AI to fight insurance denials People infrequently challenge health insurance denials even though appeals are often successful.
Gap in Biosimilar Knowledge Causes Barriers to Implementation | ASHP Midyear
Drug Topics
DECEMBER 12, 2024
Amanuel Kehasse, PharmD, PhD, explored reasons why patients and providers may be avoiding the implementation of biosimilar medications.
The biotech news you need to read today
STAT
DECEMBER 12, 2024
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, let’s get straight into the news today.
Understanding Adrenal Fatigue
Compounding Pharmacy of America
DECEMBER 12, 2024
Discover the symptoms, causes, and natural treatments for adrenal fatigue. Learn how tools like the Adrenal Stress Test Kit and targeted supplements can restore balance and energy. The post Understanding Adrenal Fatigue appeared first on Compounding Pharmacy of America.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
STAT+: Pharmalittle: We’re reading about unsupported drug price hikes, an annual HIV prevention shot, and more
STAT
DECEMBER 12, 2024
Top of the morning to you, and a fine one it is. Clear blue skies and chilly breezes are wafting across the Pharmalot campus, where the official mascots are snoozing after foraging for their breakfast. This means we are free to focus on the matters at hand — rummaging through our to-do list and making cups of stimulation. Our choice today is maple cinnamon French toast.
UK indefinitely bans puberty blockers for teenagers due to “unacceptable risk”
Pharmaceutical Technology
DECEMBER 12, 2024
Puberty blockers for people aged under 18 with gender dysphoria will be indefinitely banned by the UK Government.
STAT+: Prices for 5 drugs were hiked without proof of new benefits, costing the U.S. $815M in 2023, report finds
STAT
DECEMBER 12, 2024
During 2023, drugmakers substantially raised prices on five widely used medicines without any new clinical evidence to justify the increases, leading patients and health insurers in the U.S. to spend an additional $815 million last year, according to a new report. The drug for which spending increased the most due to a price increase was Biktarvy, which is prescribed to treat HIV and is a franchise product for Gilead Sciences.
Q&A: Pharmacist Discusses Unique Challenges in Psychiatric Population
Drug Topics
DECEMBER 12, 2024
Nina Vadiei, PharmD, BCPP, discusses some of the challenges she faces working with forensic patients who have been charged with a crime and have severe mental illness.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
STAT+: Editas Medicine lays off 65% of staff and shelves lead gene-editing program
STAT
DECEMBER 12, 2024
Editas Medicine said Thursday afternoon it will lay off 65% of its staff — around 180 employees — as it shelves its lead gene-editing program for sickle cell disease and shifts focus. The cuts come amid a prolonged financial downturn for the gene-editing field, as valuations have plummeted and layoffs have become widespread. Editas already laid off staff as part of a restructuring in 2023.
Navigating the Evolving Landscape of ER-Positive Metastatic Breast Cancer Treatment
Pharmacy Times
DECEMBER 12, 2024
Novel therapies and personalized treatment plans are improving outcomes for patients with ER-positive breast cancer.
Flu vaccine strategy on the line as new US leaders anticipated to take charge
Pharmaceutical Technology
DECEMBER 12, 2024
Public health experts are anticipating a changing discourse following RFK Jrs appointment as head of HHS.
ASHP Midyear: Pharmacists Play Key Role in Addressing Concerns and Fostering Adoption of Biosimilars
Pharmacy Times
DECEMBER 12, 2024
Pharmacists can help drive the successful adoption of biosimilars by developing educational programs to address provider and patient concerns.
China NMPA approves Santhera’s DMD treatment therapy
Pharmaceutical Technology
DECEMBER 12, 2024
Chinas NMPA has granted approval to Santhera Pharmaceuticals AGAMREE, used in treating DMD in individuals aged four years and above.
Paving the Way for Better Outcomes in HER2+ Early Breast Cancer Treatment
Pharmacy Times
DECEMBER 12, 2024
Trastuzumab deruxtecan and trastuzumab emtansine address key challenges such as recurrence and metastases in HER2+ early breast cancer treatment.
Meitheal gains US commercial rights for CABP treatment therapy
Pharmaceutical Technology
DECEMBER 12, 2024
Meitheal Pharmaceuticals has gained exclusive US commercial rights for XENLETA for treating CABP in the adult population.
FDA Grants Fast Track Designation to IMM-1-104 to Treat Advanced Melanoma
Pharmacy Times
DECEMBER 12, 2024
Currently, the treatment is undergoing evaluation in a phase 2a trial.
Is compounded semaglutide safe?
The Checkup by Singlecare
DECEMBER 12, 2024
Semaglutide has become a very popular drug thats in high demand in pharmacies everywhere and is currently also available from compounding pharmacies and online. But not all compounded semaglutide products are safe. In fact, the Food and Drug Administration (FDA) says consumers should exercise a lot of caution when considering using a compounded drug.
Study: Dark Chocolate Consumption Lowers Risk of Type 2 Diabetes
Pharmacy Times
DECEMBER 12, 2024
Pharmacists play an essential role in educating patients about various health-related topics, including type 2 diabetes and nutrition.
Noema Pharma raises $147 million to develop drugs for neurological conditions
Outsourcing Pharma
DECEMBER 12, 2024
Noema Pharma extends its series B funding to $147M, advancing phase 2 trials for CNS disorders like Tourette syndrome, menopause symptoms, and neuropathic pain.
SABCS 2024: Combination of Elacestrant and Abemaciclib Shows Promising Progression-Free Survival in ER+/HER2- Advanced Breast Cancer
Pharmacy Times
DECEMBER 12, 2024
The combination of elacestrant and abemaciclib showed promising 8.7-month progression-free survival in ER+, HER2- advanced breast cancer, including in patients with ESR1 mutations.
Prehearing Ruling Establishes Marijuana Rescheduling Hearing Ground Rules
The FDA Law Blog
DECEMBER 12, 2024
By Larry K. Houck Administrative Law Judge (ALJ) John Mulrooney conducted a prehearing conference hearing on Monday, December 2nd, to kick off the public hearing on the Department of Justices (DOJs) notice of proposed rulemaking (NPRM) to reschedule marijuana. The NPRM seeks to reschedule marijuana from schedule I of the federal Controlled Substances Act (CSA) to schedule III.
Belumosudil Commonly Used in Combination and After 3 or More Prior Lines of Therapy in Patients With cGVHD
Pharmacy Times
DECEMBER 12, 2024
Patients with chronic graft-versus-host disease (cGVHD) were most likely to receive belumosudil in the fourth line (33.7%) setting or the fifth through seventh line (33.1%).
The Pharmacy Owner’s Guide to Navigating PBM Headaches in 2025
DiversifyRx
DECEMBER 12, 2024
PBM headaches will still be around in 2025. Get your guide to making them just a wee bit better. PBMthose three little letters have caused more headaches for independent pharmacy owners than we care to count. Just when you think you’ve figured out their latest reimbursement trick, they hit you with another clawback, new DIR fee structure, or policy that leaves you questioning why you even got into this business.
Let's personalize your content